ACTU (Actuate Therapeutics) Other Stockholders Equity : $-0.00 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Actuate Therapeutics Other Stockholders Equity?

Actuate Therapeutics's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $-0.00 Mil.

Actuate Therapeutics's quarterly Other Stockholders Equity increased from Jun. 2024 ($-0.00 Mil) to Sep. 2024 ($0.00 Mil) but then declined from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Actuate Therapeutics's annual Other Stockholders Equity declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) and declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Actuate Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Actuate Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actuate Therapeutics Other Stockholders Equity Chart

Actuate Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Other Stockholders Equity

Actuate Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial				-	-	-	-	-

Actuate Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Actuate Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Actuate Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Actuate Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actuate Therapeutics Inc (NAS:ACTU) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1751 River Run, Suite 400, Fort Worth, TX, USA, 76107

Website

https://www.actuatetherapeutics.com

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.